Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: A clinical study on bone defect reconstruction and functional recovery in benign bone tumors of the lower extremity, treated by bone marrow mesenchymal stem cell rapid screening–enrichment–composite system

Fig. 2

Evaluation of the osteogenic effects of mesenchymal stem cell (MSC)/TCP bioactive scaffolds in vivo (n = 5). a The control group showed less osteogenesis. b However, there were more new bone components in the experimental group, which distributed in a reticular manner. c The osteogenic effects in the experimental group were statistically higher than the control group (P < 0.05)

Back to article page